Wanqiong Li

机构：Tongji University, Sun Yat-sen University, The Seventh Affiliated Hospital of Sun Yat-sen University, China General Nuclear Power Corporation (China), Tongji Hospital · ORCID：0009-0009-9994-1815

发表论文 45 篇 · 总被引 1240 次 · h-index 15

代表论文

• Oral delivery of protein and peptide drugs: from non-specific formulation approaches to intestinal cell targeting strategies (2022 · Theranostics · 被引 158)
• An orally available PD-1/PD-L1 blocking peptide OPBP-1-loaded trimethyl chitosan hydrogel for cancer immunotherapy (2021 · Journal of Controlled Release · 被引 93)
• A covalent peptide-based lysosome-targeting protein degradation platform for cancer immunotherapy (2025 · Nature Communications · 被引 80)
• Dual Blockade of Lactate/GPR81 and PD-1/PD-L1 Pathways Enhances the Anti-Tumor Effects of Metformin (2021 · Biomolecules · 被引 56)
• Fish oil-based microemulsion can efficiently deliver oral peptide blocking PD-1/PD-L1 and simultaneously induce ferroptosis for cancer immunotherapy (2023 · Journal of Controlled Release · 被引 35)
• Design of a novel chimeric peptide via dual blockade of CD47/SIRPα and PD-1/PD-L1 for cancer immunotherapy (2023 · Science China Life Sciences · 被引 35)